Arakis Limited
Arakis Limited focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Arakis Limited Information
Arakis Limited was acquired by
Sosei Group.
The acquisition happend on 2005-07-19.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: London
State: England
Zip:
Country: United Kingdom
Financial Info
Stage:
series c
Raised Last:
$52M
Raised Total:$81M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Arakis Limited is focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy. The company&s;s research capability specializes in the cytokine and receptor mediated mechanisms of disease. The company identifies, develops, and commercializes product opportunities based upon new clinical uses for known drugs or known drug templates, as well as termed performance enhanced medicines.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2002 | Series B | 4 | $23.3M |
3i Group Alice Ventures Excalibur Fund Managers Nomura International 3i Group Alice Ventures Excalibur Fund Managers Nomura International |
8/2000 | Venture Round | 2 | $5.8M |
Alice Ventures Excalibur Fund Managers Alice Ventures Excalibur Fund Managers |
9/2004 | Series C | 2 | $51.6M |
Novo Holdings Scottish Equity Partners Novo Holdings Scottish Equity Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
